The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have become the mainstay of treatment for advanced renal cell carcinoma (RCC), but it has been unclear whether the antitumor effect of TKIs depends on the organ where the RCC metastasis is located. We previously reported that the FDG accumulation assesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakizoe, Manabu, Yao, Masahiro, Tateishi, Ukihide, Minamimoto, Ryogo, Ueno, Daiki, Namura, Kazuhiro, Makiyama, Kazuhide, Hayashi, Narihiko, Sano, Futoshi, Kishida, Takeshi, Kobayashi, Kazuki, Noguchi, Sumio, Ikeda, Ichiro, Ohgo, Yoshiharu, Taguri, Masataka, Morita, Satoshi, Inoue, Tomio, Kubota, Yoshinobu, Nakaigawa, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067124/
https://www.ncbi.nlm.nih.gov/pubmed/24885730
http://dx.doi.org/10.1186/1471-2407-14-390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067124/
https://www.ncbi.nlm.nih.gov/pubmed/24885730
http://dx.doi.org/10.1186/1471-2407-14-390

Ejemplares similares